Seeing Is Believing
BLTE is currently covered by 2 analysts with an average price target of $76.44. This is a potential upside of $12.32 (19.21%) from yesterday's end of day stock price of $64.12.
Belite Bio ADR's activity chart (see below) currently has 2 price targets and 22 ratings on display. The stock rating distribution of BLTE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 96.67% with an average time for these price targets to be met of 387 days.
Highest price target for BLTE is $100, Lowest price target is $57, average price target is $76.44.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 13-Nov-2024. First documented stock forecast 01-Jul-2022.
Currently out of the existing stock ratings of BLTE, 20 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$100
$35.88 (55.96%)
$60
1 months 8 days ago
(13-Nov-2024)
14/15 (93.33%)
$18 (21.95%)
355
Buy
$57
$-7.12 (-11.10%)
$57
4 months 8 days ago
(13-Aug-2024)
7/7 (100%)
$6.64 (13.19%)
419
What is BLTE (Belite Bio ADR) average time for price targets to be met?
Which analyst has the current highest performing score on BLTE (Belite Bio ADR) with a proven track record?
Which analyst has the current lower performing score on BLTE (Belite Bio ADR) with a proven track record?
Which analyst has the most public recommendations on BLTE (Belite Bio ADR)?
Which analyst is the currently most bullish on BLTE (Belite Bio ADR)?
Which analyst is the currently most reserved on BLTE (Belite Bio ADR)?